Maladie de Fabry en cardiologie revue de la littérature et point de vue d’experts [Fabry disease in cardiology practice Literature review and expert point of view]

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Fabry disease revisited: Management and treatment recommendations for adult patients.

  2018cited by this paper
• Echocardiographic Assessment of Patients with Fabry Disease

  2018cited by this paper
• European expert consensus statement on therapeutic goals in Fabry disease.

  2018cited by this paper
• Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study

  2018cited by this paper
• Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice

  2018cited by this paper
• Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)

  2017cited by this paper
• Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.

  2017influential reference
• Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.

  2016cited by this paper
• High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease

  2016influential reference
• Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease

  2016cited by this paper
• Cardiac device implantation in Fabry disease

  2016cited by this paper
• Cardiac involvement in genotype-positive Fabry disease patients assessed by cardiovascular MR

  2016cited by this paper
• X‐chromosome inactivation in female patients with Fabry disease

  2016cited by this paper
• Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.

  2016cited by this paper
• Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.

  2016cited by this paper
• Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy

  2016cited by this paper
• Later Onset Fabry Disease, Cardiac Damage Progress in Silence: Experience With a Highly Prevalent Mutation.

  2016cited by this paper
• Arrhythmias in Fabry cardiomyopathy.

  2015influential reference
• Adult patients with Fabry disease: what does the cardiologist need to know?

  2015cited by this paper
• Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease.

  2014cited by this paper
• Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease

  2014cited by this paper
• Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry

  2013cited by this paper
• Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications

  2013influential reference
• Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry disease.

  2013cited by this paper
• Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping

  2013cited by this paper
• T1 Mapping With Cardiovascular MRI Is Highly Sensitive for Fabry Disease Independent of Hypertrophy and Sex

  2013cited by this paper
• Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey

  2011influential reference
• Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease.

  2011cited by this paper
• Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease.

  2011cited by this paper
• The use of dried blood spot samples in the diagnosis of lysosomal storage disorders--current status and perspectives.

  2011cited by this paper
• Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.

  2011cited by this paper
• Exercise-induced left ventricular outflow tract obstruction in symptomatic patients with Anderson-Fabry disease.

  2011cited by this paper
• Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity.

  2010cited by this paper
• Aortic remodelling in Fabry disease.

  2010cited by this paper
• Cardiovascular events in patients with fabry disease natural history data from the fabry registry.

  2010cited by this paper
• Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study

  2010cited by this paper
• Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy: Evidence for a Better Outcome With Early Treatment

  2009cited by this paper
• Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry

  2009cited by this paper
• [Fabry disease].

  2009influential reference
• Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survey

  2009cited by this paper
• Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement

  2008cited by this paper
• Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry's disease.

  2007cited by this paper
• Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy.

  2007cited by this paper
• Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

  2007influential reference
• High incidence of later-onset fabry disease revealed by newborn screening.

  2006cited by this paper
• The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease.

  2006cited by this paper
• Fabry Disease: Percutaneous Transluminal Septal Myocardial Ablation Markedly Improved Symptomatic Left Ventricular Hypertrophy and Outflow Tract Obstruction in a Classically Affected Male

  2005cited by this paper
• Cardiac transplantation for Fabry's disease.

  1998cited by this paper

• Left atrial strain tracks abnormal ventricular mechanics in Fabry disease

  2025cites this paper